Efficacy of NY-198 against experimental Legionnaires disease.

The in vitro and in vivo effects of NY-198 against Legionella pneumophila were compared with those of ciprofloxacin. The MIC of NY-198 against 15 standard reference strains of Legionella of various species, between 0.03 and 0.125 micrograms/ml, was the same as that of ciprofloxacin. The peak concent...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kohno, S, Yamaguchi, K, Dohtsu, Y, Koga, H, Hayashi, T, Hirota, M, Saito, A, Hara, K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175881/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3196003/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.9.1427
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!